18 results
8-K
EX-99.1
NVCR
NovoCure Ltd
8 Jan 24
Novocure Announces Preliminary Full Year and Fourth Quarter 2023 Net Revenues and Provides Company Update
7:10am
mission to extend patient survival in some of the most aggressive forms of cancer.”
Financial updates for the year and quarter ended December 31, 2023
8-K
EX-99.1
NVCR
NovoCure Ltd
4 Jan 24
Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer
4:10pm
as a dedication to patients that is core to Novocure’s mission. I am confident that his expertise will be instrumental as Novocure enters its next
8-K
EX-99.1
NVCR
NovoCure Ltd
28 Nov 23
Regulation FD Disclosure
7:30am
potential and fulfill our mission.”
Key elements of the plan include:
Portfolio prioritization
Novocure has taken a holistic review of operating
8-K
EX-99.1
rszrmp
28 Aug 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
fhtwome4g3prbmz kl
21 Jul 23
Regulation FD Disclosure
8:00am
8-K
EX-99.1
t4uok7fro1nkza23so
27 Oct 22
Novocure Reports Third Quarter 2022 Financial Results
7:20am
8-K
EX-99.1
rjqyar85
25 Feb 21
Novocure Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Company Update
6:30am
8-K
EX-99.1
63e71h 2lo4
13 Aug 20
Novocure Announces Expansion of its Executive Leadership Team
8:45am
8-K
EX-99.1
2gs68lep
30 Apr 20
Novocure Reports First Quarter 2020 Financial Results and Provides Company Update
6:13am
8-K
EX-99.1
1e1wlgk2pnck
6 Jul 18
Novocure Appoints Pritesh Shah as Chief Commercial Officer
4:05pm
- Prev
- 1
- Next